Objective: Brain-derived neurotrophic factor (BDNF) is involved in the pathophysiology of psychiatric disorders in adults and elderly individuals, and as a result, the DNA methylation (DNAm) of the BDNF gene in peripheral tissues including blood has been extensively examined to develop a useful biomarker for psychiatric disorders. However, studies to date have not previously investigated the effect of age on DNAm of the BDNF gene in blood. In this context, we measured DNAm of 39
| INTRODUCTION
Numerous epidemiological studies have demonstrated that aging is associated with the development of brain disorders, such as depression and dementia. [1] [2] [3] [4] [5] Although the precise mechanisms by which aging increases the susceptibility to brain disorders have not been fully elucidated, it is likely that altered gene expression in the brain caused by aging is a major risk factor for brain disorders in late life. 6 For example, it is well known that the brain levels of brain-derived neurotrophic factor (BDNF) are decreased with normal aging as well as in patients with Alzheimer's disease. 7, 8 In addition, an age-related decrease in BDNF transcript in the brain has also been reported in patients with major depression. 9 Based on the physiological function of BDNF, such as in the regulation of neural plasticity and survival, it is conceivable that downregulation of BDNF is associated with the increased susceptibility to brain disorders in the elderly.
Recent advances in molecular biology reveal that epigenetic regulation of gene transcription, such as DNA methylation and histone acetylation, is closely involved in gene expression. In this context, it is plausible that the aging-associated changes in gene expression may be because of alteration in DNA methylation (DNAm) in the brain.
In fact, several studies have demonstrated age-associated DNAm, such as hypermethylation or hypomethylation, in the brain. [10] [11] [12] [13] [14] With regard to BDNF, Keleshian and associates 15 reported that the methylation rate at promoter I of the BDNF gene in the frontal cortex was positively correlated with aging. McKinney and colleagues 16 also demonstrated that methylation levels at the promoters of the BDNF gene in the orbital frontal cortex in an elderly cohort were higher than those in a younger cohort.
Although abnormal gene methylation in the brain in late life is thought to increase vulnerability to geriatric brain disorders, agingdependent changes in DNAm in postmortem brain are not an appropriate biomarker for aging or these disorders. In contrast, if DNAm in blood and brain are correlated, then blood DNAm may be a promising biomarker for aging and geriatric brain. Several genome-wide DNAm studies using blood DNA have demonstrated aging-associated DNA hypermethylation or, to a lesser extent, hypomethylation. [17] [18] [19] [20] [21] [22] In addition, Horvath and coworkers 23 revealed an age-related comethylation module in human brain and blood and suggested that blood methylation could be a promising surrogate for brain methylation.
As mentioned above, studies in postmortem brain have indicated that the methylation status of the BDNF gene is decreased by aging.
However, no studies to date have examined the effect of aging on blood DNAm status of the BDNF gene. Thus, we hypothesized that the methylation status of the BDNF gene might be decreased by aging in healthy subjects, and that it could serve as a good biomarker for cognitive decline. We addressed this in the present study by first examining the influence of aging on DNAm at the promoter of exon I of the BDNF gene in blood within a Japanese female population.
Second, we examined whether the blood DNAm status affected cognitive function in elderly subjects as measured by the Mini Mental State Examination (MMSE). 24 Third, we examined whether stressful life events in late life affected the status of blood DNAm of the BDNF gene.
| MATERIALS AND METHODS

| Subjects
All subjects in the present study were healthy women who participated in 1 of 3 surveys conducted in Japan between 2013 and 2015, and who had been diagnosed by psychiatrists as nondepressive during the survey (ie, without any history of major depression).
Although healthy men were also included in 2 of 3 surveys, the cohorts of male participants were relatively small. In addition, it was reported that there was a propensity for greater DNAm at the promoter of exon I of the BDNF gene in the blood of female healthy subjects. 25 Consequently, we measured DNAm of the BDNF gene in female subjects only. The 3 surveys included a self-administered depression scale and additional psychiatric evaluation using the Structured Clinical Interview for DSM-IV or the Mini-International Neuropsychiatric Interview. 26 Data for 105 women whose blood samples were available were subsequently studied.
| DNA methylation analysis by MassARRAY
With respect to proximal promoter activity and preinitiation, the first exon of a gene is generally considered to be important in transcription. 27 In addition, we previously showed that the analyses of the DNAm profiles of the CpG island at the promoter of exon I of the BDNF gene (CpG I) distinguished between healthy subjects and patients with major depression. 28 In this context, we chose the CpG I as a target for methylation analysis. As in our previous study, the CpG I sequence was identified using the UCSC genome browser 
Key points
• A significant correlation was found between the methylation rate of 13 CpGs at the promoter of exon I of the BDNF gene from blood DNA and age in Japanese female healthy subjects.
• The positive correlation between the methylation rate of 11 CpGs of exon I of the BDNF gene from blood DNA and age is in good agreement with that in human postmortem frontal cortex.
• The methylation rate of 13 CpGs of the BDNF gene may be appropriate biomarker for aging.
described in our previous study. 28 The method yields quantitative results for each of the sequence-defined analytic units referred to as 
| Serum BDNF measurement
Serum BDNF levels were measured in subjects 65 years of age or older, using the Emax Immuno Assay System (Promega Corp.,
Madison, WI, USA) according to the manufacturers' protocol. The standard curve was linear from 7.8 to 500 pg/mL, and the detection limit was 10 pg/mL.
| Life events and the Mini-Mental State Examination
Life events of subjects 65 years of age or older were identified at the psychiatric evaluation after the second of the 3 surveys. The psychiatrists asked them about their experience of negative events 1 year prior to the psychiatric evaluation using a semistructured interview form. Each subject's experiences of severe physical illness or injury, which left or might have left sequelae, were recorded on the form.
Each experience of death and severe physical illness or injury of their husband, children, parents, siblings, other relatives, friends, and neighbors was also recorded. Finally, the total number of the life events on the form was counted for each of the older subjects.
The MMSE was carried out for all subjects 65 years of age or older by trained psychologists at the surveys. Those who scored 23 points or less on the MMSE were not included among the final population in the study.
| Statistical analysis
We first described the proportions of categorized characteristics of the subjects and the medians and ranges of the DMRs of 39 units at CpG I of the BDNF gene. The associations between age and DMRs were then examined by Spearman's correlation analyses. Furthermore, the associations between DMRs and total MMSE scores, numbers of stressful life events during 1 year prior to psychiatric evaluation, and serum BDNF levels in subjects 65 years of age or older were analyzed using Spearman's correlation analyses. All statistical analyses were performed using SPSS Statistics 23 (IBM, Corp., New York, NY, USA).
This study was approved by the ethics committee of the Toho University Faculty of Medicine. Written informed consent was obtained at psychiatrist assessments.
| RESULTS
The characteristics of the subjects are shown in the Among the samples from elderly subjects, none of DMRs of the CpGs unit were correlated with the total MMSE score (Table 3) .
Although DMRs of CpG_47 and CpG_76 units among all 39 CpG units were only correlated with the number of life events, the 2 correlations
were not statistically significant when considering multiple comparisons (P = .117 and .429 with Bonferroni correction) ( Table 3 ). The correlation found between DMR of CpG_79 and serum BDNF protein levels did not persist after Bonferroni correction (corrected P = .702) (Table 3) .
| DISCUSSION
The results of the present study demonstrate that DMRs of 13 CpGs While no study to date has examined the relationship between age and blood levels of total or exon I BDNF mRNA in healthy subjects, a significant negative correlation is known to exist between age and BDNF protein levels in blood. 31 Whereas DNAm directly regulates gene transcription mediated by changes in chromatin structure, DNAm has no direct effect on expression beyond the transcription step. In this context, it is unlikely that hypermethylation of CpG I directly leads to the decrease in serum BDNF levels. In fact, there was no correlation between DMRs and serum BDNF levels in this study. In addition, although Pan and colleagues 32 showed the transport of BDNF across the blood-brain barrier, it is known that plasma BDNF is, at least in part, derived from the muscle. 33, 34 In this context, plasma BDNF is derived from both the brain and muscle. Brainderived neurotrophic factor derived from the muscle varies according to the intensity and type of exercise. We therefore surmise that brain tissue RNA expression does not correlate with serum BDNF levels.
A recent systematic review and meta-analysis of studies that have examined blood BDNF levels in patients with Alzheimer's disease (AD) and healthy subjects indicated that AD patients with a low MMSE score (<20) had lower blood BDNF levels. 35 In line with the relationship between DNMs of the BDNF gene and MMSE scores in patients with Alzheimer's disease, Nagata and colleagues 36 reported that there was no significant correlation between DMRs of 1 CpG at the promoter of exon I of the BDNF gene and total MMSE scores. In the present study, we found that no relationship existed between DMRs of CpG I and total MMSE scores. This finding indicated that the increase in aging-associated DMRs had no effect on cognitive decline in healthy subjects. Further studies examining DMRs in subjects with a lower total MMSE score are needed to elucidate the influence of DMRs of the BDNF gene on cognitive impairment.
A wide body of evidences [37] [38] [39] with major depression as compared with healthy subjects. 28 Keller et al 42 reported that DMRs at the promoter of exon IV of the BDNF gene in the Wernicke area of subjects who had committed suicide were higher than those of nonsuicide control subjects. It is therefore plausible that stressful events can affect DMRs of the BDNF gene.
Thus, we analyzed the number of stressful events that occurred within approximately 1 year prior to blood collection in all elderly subjects to evaluate the influence of stress exposure on DMRs at CpG I. Based on our findings, it appears that stress exposure which does not lead to mental dysfunction has no influence on DMRs at CpG I of the BDNF gene.
Overall, the results of the present study suggest that aging may cause secondary DNAm changes, although the precise mechanism Some limitations of the current study warrant mention. First, the sample size in the current study was relatively small. In addition, DMRs were analyzed in female, but not male subjects. Second, we analyzed the number of stressful events occurring within approximately 1 year prior to blood collection, but we did not obtain any information about early adversities, such as physical abuse or neglect. The results of the rodent studies indicate that early adversities, such as maternal separation or poor maternal care, can result in altered DNA methylation profiles, which persist into adulthood. [44] [45] [46] It is therefore difficult to exclude the possibility that early adversities can change DMRs and subsequently lead to a significant correlation between DMRs at CpG I and age. Third, we did not examine the influence of single nucleotide polymorphisms (SNPs) such as rs6265 (val66met), on DMRs at CpG I of the BDNF gene, although the influence of SNP (rs6265) on DMRs at CpG I of the BDNF gene in blood remains unclear. 47, 48 In summary, we demonstrated a significant correlation between age and DMRs of 8 CpGs ( 
